A new study found that many people starting combination therapy for type 2 diabetes face long-term adherence challenges.
Live Poll
Do you find it difficult to maintain a consistent schedule for your prescribed daily medications?
September 22, 2026
FDA Issued Warning to Houston Pharmacy Over GLP-1 DrugsThe federal agency raised concerns about the manufacturing and clinical oversight of compounded medications for local patients.
September 21, 2026
Eli Lilly Began Construction on Houston Diabetes CampusThe 236-acre facility will produce orforglipron, an oral medication approved in 2026 for diabetes management.
